Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
334 Leser
Artikel bewerten:
(1)

Alpha II LLC: Alpha II, LLC and Greenway Health to be Featured in Award-Winning Documentary Series, Viewpoint with Dennis Quaid

TALLAHASSEE, FL / ACCESSWIRE / April 5, 2022 / Leading healthcare software solutions and service providers, Alpha II, LLC and Greenway Health, LLC, will be featured in the award-winning documentary series, Viewpoint with Dennis Quaid.

"As a leader in healthcare technology, we were honored to be invited by the Viewpoint team to participate in an educational segment focused on technology and its impact on improving the efficiency and quality of delivering healthcare services," said Todd Doze, Alpha II CEO. "Collaborating on this project with David [Cohen] and our partners at Greenway was a phenomenal experience, as they share the same values and passion for healthcare innovation as Alpha II."

This educational segment produced by Viewpoint, will outline many of the challenges healthcare providers are facing today and how innovative technology solutions are changing the healthcare industry. David Cohen, Greenway Health Chief Product and Technology Officer, believes in developing technology solutions that allow practices to thrive. "The current healthcare environment is incredibly complex for physicians to navigate, driven by regulatory pressures and payment reform. Our main focus in health information technology today is to deliver client-driven technology solutions that drive successful providers, empowered patients, and healthier communities," said Cohen.

The segment will also highlight the importance of technology as it relates to the non-clinical aspect of the patient experience. "In healthcare, we are all dedicated to one single thing - to improve patient care and provide the best patient experience from both the clinical and non-clinical aspects of service," Jamie Hill-Walters, Alpha II SVP Client Services explains. "Technology in our space is extremely important to provide efficiency and to remove the administrative burden of our clinicians and healthcare leaders, allowing them to provide exceptional patient care and improve patient outcomes."

Viewpoint's creative team produces meaningful short-form public television documentaries to educate and inspire audiences. Each production results in an educational segment for Public Television which is distributed nationally. Additionally, Alpha II will be featured in a separate branded commercial campaign that will be distributed regionally and nationally.

About Alpha II
For decades, Alpha II's experienced healthcare professionals have worked together to gather, analyze, and interpret healthcare coding and billing rules and regulations. That continuing effort and extensive experience has produced the industry's most comprehensive content database and rules engine available. As a result, the company is well positioned to help large groups, hospital systems, and individual healthcare providers nationwide maintain compliance and achieve accurate reimbursement. Further, the company's software, when embedded into leading EMR/PM software solutions, RCM platforms, and clearinghouses, provides a significant differentiator and growth engine for its reseller partners.

For additional information, please visit Alpha II's website, call (800) 476-8477, or follow us on LinkedIn, Twitter, and YouTube.

About Greenway Health
Greenway Health provides electronic health records (EHR), practice management, and revenue cycle management solutions helping practices in multiple specialties grow profitably, remain compliant, work more efficiently, and improve patient outcomes. Its team of clinical, financial, and technology experts serve as trusted advisors, committed to the success of its providers, empowering patients, and building healthier communities. Greenway works with more than 55,000 providers across multiple specialties, translating into millions of lives touched daily by its solutions. For more information on Greenway and its holistic solutions, visit www.greenwayhealth.com, call 877-537-0063, or follow Greenway on Facebook, Twitter, and LinkedIn.

CONTACT:
Renée Durrance
Alpha II, LLC
info@alphaii.com
(800) 476-8477

SOURCE: Alpha II, LLC



View source version on accesswire.com:
https://www.accesswire.com/696025/Alpha-II-LLC-and-Greenway-Health-to-be-Featured-in-Award-Winning-Documentary-Series-Viewpoint-with-Dennis-Quaid

© 2022 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.